Biotech Firm Pandorum Technologies To Raise US$10 Mn in Series B

The article reports that Pandorum Technologies, an Indian biotech company, is preparing a Series B funding round aiming to raise US$10 million. The infusion of capital is expected to support R&D, product development, and scaling of operations. This reflects growing investor interest in deep-tech and biotech ventures, especially those focused on healthcare and biotech innovation. For stakeholders, the funding round indicates confidence in the firm’s technology, pipeline, and long-term vision — a trend relevant for the evolving Indian biotech ecosystem and startup funding landscape.